Antiproliferative Effects of EGFR inhibitor Cetuximab and PARP Inhibitor Combination on Non-Small Cell Lung Cancer Cell Line A549 and Cervical Cancer Cell Line HeLa.


Çetin İ., Topçul M. R.

Cellular and molecular biology (Noisy-le-Grand, France), vol.68, no.8, pp.47-51, 2022 (SCI-Expanded) identifier